Search Results - "A Yu Abrosimov"

Somatic Mutations in the BRAF, KRAS, NRAS, EIF1AX, and TERT Genes: Diagnostic Value in Thyroid Neoplasms by Kachko, V. A., Vanushko, V. E., Platonova, N. M., Abrosimov, A. Yu, Mel’nichenko, G. A.

“…The feasibility of using molecular genetic markers associated with thyroid neoplasms and more aggressive course of the disease is now actively studied. We…”
Get full text

Thyroid follicular cell tumors: cytohistological comparisons in the context of the new international classification by Abrosimov, A Yu, Abdulkhabirova, F M, Shifman, B M

“…To carry out a correlation retrospective analysis of the histological and cytological findings of follicular cell neoplasms over a two-year period after the…”
Get more information

Histopatological and molecular genetic characteristics of clinically aggressive variants of papillary thyroid carcinoma by Bogolyubova, A V, Abrosimov, A Yu, Selivanova, L S, Belousov, P V

“…Papillary carcinoma is the most commonly diagnosed form of well-differentiated thyroid cancer that is generally characterized by a favorable prognosis…”
Get more information

Cells of Benign and Borderline Thyroid Tumor Express Malignancy Markers by Abrosimov, A. Yu, Dvinskikh, N. Yu, Sidorin, A. V.

“…We studied expression of malignancy markers galectin-3, cytokeratin-19, HBME-1, fibronectin, and cyclin D1 in cells of benign ( n =51), malignant ( n =87), and…”
Get full text

Pituitary lactotroph adenomas resistant to dopamine agonist treatment: histological and immunohistochemical characteristics by Fedorova, N S, Abrosimov, A Yu, Dzeranova, L K, Pigarova, E A, Dedov, I I

“…To present the histological and immunohistochemical characteristics of pituitary lactotroph adenomas (PLAs) resistant to dopamine agonist treatment. The…”
Get more information

Consensus position of endocrinologists and pathologists on coding causes of death in patients with diabetes mellitus (expert opinion) by Dedov, I. I., Frank, G. A., Mokrisheva, N. G., Shestakova, M. V., Melnichenko, G. A., Zayratyants, G. V., Malkov, P. G., Abrosimov, A. Yu, Vikulova, O. K., Galstyan, G. R., Mayorov, A. Yu, Troshina, E. A., Kalashnikov, V. Yu

“…Coding of the causes of death of patients with diabetes mellitus (DM) in the Russian Federation is one of the long-discussed problems, due to the comorbidity…”
Get full text

DETECTION OF AUTOANTIBODIES RECOGNIZING CANCERRETINA ANTIGEN RECOVERIN IN BLOOD OF PATIENTS WITH NON-INVASIVE FOLLICULAR THYROID NEOPLASMS WITH PAPILLARY-LIKE NUCLEAR FEATURES (NIFTP) by Belousov, P. V., Bobrovskaya, Ya. I., Bogolyubova, A. V., Sazykin, A. Yu, Shebzukhov, Yu. V., Schwartz, A. M., Lanshchakov, K. V., Vanushko, V. E., Kuprash, D. V., Abrosimov, A. Yu

“…Autoantibodies recognizing the cancer-retina autoantigen called recoverin (RCVRN-AutoAb) may serve as a highly specific biomarker of cancer-associated…”
Get full text

TREATMENT OF BRAFV600E POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT by Nikiforovich, P. A., Rumiantsev, P. O., Sleptsov, I. V., Ustinova, T. V., Slashchuk, K. Yu, Vorobyev, S. L., Serzhenko, S. S., Abrosimov, A. Yu, Kudryavtseva, A. V., Semenov, A. A., Chernikov, R. A., Polyakov, A. A., Fedenko, A. A., Bolotina, L. V., Paychadze, A. A., Trushin, A. Y., Kaprin, A. D., Zakharova, G. S.

“…Anaplastic thyroid cancer is one of the most aggressive and fatal human carcinomas. A significant experience in using various kinase inhibitors for anaplastic…”
Get full text

Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma by Selivanova, L S, Roslyakova, A A, Bogolyubova, A V, Tertychnyi, A S, Beltsevich, D G, Abrosimov, A Yu, Melnichenko, G A

“…Studies of the last decade have demonstrated that the morphological and immunophenotypic patterns of adrenocortical carcinoma (ACC) have a high heterogeneity…”
Get more information

Telomerase reverse transcriptase (TERT) promoter mutations in the tumors of human endocrine organs: Biological and prognostic value by Selivanova, L S, Volganova, K S, Abrosimov, A Yu

“…The analysis of the data available in the literature has shown that telomerase reverse transcriptase TERT promoter may serve as promising markers of…”
Get more information

Clinical, morphological, and prognostic features of papillary thyroid carcinoma with different BRAF mutational status assessed by immunohistochemistry by Sidorin, A V, Abrosimov, A Yu, Rogunovich, T I, Rumyantsev, P O, Nizhegorodova, K S, Isaev, P A, Shinkarkina, A P, Yamasita, S, Saenko, V A

“…The somatic mutation in BRAF (BRAF ), the data on the prognostic role of which are contradictory, is one of the most common molecular genetic abnormalities in…”
Get more information

Autoantibody profiling of benign and malignant thyroid tumors and design of a prototype diagnostic array by Lanshchakov, K V, Belousov, P V, Vanushko, V E, Abrosimov, A Yu, Kuprash, D V, Kuznetsov, N S

“…Currently the “gold standard” in diagnostics of thyroid tumors is a fine-needle aspiration cytology (FNAC). However, FNAC cannot discriminate between benign…”
Get full text

High-grade encapsulated follicular cell thyroid carcinomas by Abrosimov, A Yu, Kuryshev, A A

“…In accordance with the 2022 WHO classification of thyroid tumors there is a new group of high grade follicular cell-derived malignances which include both…”
Get more information

Problem of prevalence of ret/PTC rearrangements in thyroid tumors by Saenko, V A, Rogounovitch, T I, Abrosimov, A Yu, Takamura, N, Lushnikov, E F, Namba, H, Yamashita, S

Get more information

Clinical and genetic heterogeneity of micronodular adrenal hyperplasia by Chevais, A., Beltsevich, D. G., Abrosimov, A. Yu, Derkatch, D. A., Lazareva, A. A.

“…Micronodular adrenal hyperplasia is a rare cause of ACTH-independent Cushing syndrome. It can be divided into two entities: primary pigmented nodular…”
Get full text

Parathyroid carcinoma case-report in a patient with multinodular goiter and chronic kidney disease: difficulties in diagnosis and treatment (observation from practice) by Averkina, A. A., Zolotareva, R. A., Kim, I. V., Bondarenko, E. V., Abrosimov, A. Yu, Degtyarev, M. V., Mamedova, E. O., Belaya, Zh. E., Rozhinskaya, L. Ya

“…We would like to present a clinical case of severe primary hyperparathyroidism due to a parathyroid carcinoma of atypical location in a patient with chronic…”
Get full text

Monograph review by Kit O. I., Shaposhnikov A. V. General carcinogenesis. Exogenous tumorogenic effects. Rostov-on-Don: LLC "Don Publishing House"; 2022, 128 p by A. Yu. Abrosimov

“…The second part of a three-component work on gen- eral carcinogenesis has been published. The first part (2021) deploys modern theories, models of general…”
Get full text

High-grade thyroid cancer by Abrosimova, A Iu, Sidorin, A V, Shinkarkina, A P

“…The paper analyzes the data available in the literature on the morphological and prognostic features of relatively rare high-grade thyroid cancer. It shows the…”
Get more information

Medullary Thyroid Cancer: Management Guidelines by Abdulkhabirova, F M, Bel'tsevich, D G, Vanushko, V E, Dedov, I I, Kuznetsov, N S, Mel'nichenko, G A, Platonova, N M, Rumyantsev, P O, Troshina, E A, Tyul'pakov, A N, Fadeev, V V, Kropotov, M A, Lyubchenko, L N, Mudunov, A M, Podvyaznikov, S O, Polyakov, V G, Romanov, I S, Subramanian, S, Tyulyandin, S A, Brzhezovskiy, V Zh, Abrosimov, A Yu, Il'in, A A, Isaev, P A, Medvedev, V S, Rumyantseva, U V, Ol'shanskiy, V O, Reshetov, I V, Makhson, A N, Bondarenko, V O, Vetshev, P S, Zaletaev, D V, Ivanov, Yu V, Kozhanov, L G, Soldatov, I V, Kharnas, S S, Barchuk, A S, Bershteyn, L M, Sleptsov, I V, Chernikov, R A, Bubnov, A N, Grineva, E N, Manikhas, G M, Romanchishen, A F, Korenev, S V, Vikhlyanov, I V, Gashchenko, A D, Dvornichenko, V V, Kiyaev, A V, Privalov, V A, Yaytsev, S V, Svetitskiy, P V, Khasanov, R Sh, Tsvetaev, V A, Choynzonov, E L, Shevchenko, S P

Get full text

The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid by Abrosimov, A Iu, Dvinskikh, N Iu, Makanin, M A, mal'kov, P G, Grinevich, V N

“…The paper considers the morphological features of a rare hyalinizing trabecular tumor of the thyroid, which is of follicular cell origin. The signs of invasive…”
Get more information